David W. Dawson

Tumorigenesis and Neoplastic Progression Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer

M. Burdick, R. Strieter, Jonathan C. King, 2011 .

Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors.

M. Girgis, Michael A. Mederos, O. Joe Hines, 2024, Journal of surgical oncology.

Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness

D. Iliopoulos, G. Poultsides, C. Polytarchou, 2024, Gastro hep advances.